可调节药物释放的超疏水材料:使用空气的位移来控制释放速度
Stefan T Yohe1, Yolonda L Colson, Mark W Grinstaff
1Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, USA.
Journal of the American Chemical Society
|January 28, 2012
概括
我们开发了3D超水材料,使用生物相容的聚合物来控制药物释放. 这些多孔网格利用被困空气来调节药物化,显示出对长期输送应用的希望.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 表面化学 表面化学
背景情况:
- 控制药物释放对于有效的治疗结果至关重要.
- 超疏水材料为调节流体相互作用提供独特的特性.
- 生物相容的聚合物对于医疗应用是可取的.
研究的目的:
- 为可调节的药物释放设计3D超疏水材料.
- 调查被困空气在控制药物化率中的作用.
- 为了证明这些材料在药物输送中的长期有效性.
主要方法:
- 使用疏水性聚合物添加剂制造的聚-ε-caprolactone) 电网.
- 使用明显接触角测量对网状超水性进行表征.
- 在实验室中使用模型生物活性剂 (SN-38) 进行药物释放研究.
- 对材料的稳定性和对癌细胞的体外疗效的评估.
主要成果:
- 超疏水性网格表现出高的表面接触角度,控制水的透和空气的移位.
- 药物释放率表现出强烈依赖于明显的接触角度,与空气位移有关.
- 与无孔对照组相比,具有较高表面积的多孔网格表现出较慢的释放率.
- 被捕获的空气层在血清中被证明是强大的,在60多天内保持有效性.
结论:
- 3D超疏水电网为控制药物输送提供了一个强大的平台.
- 可调节的释放动力学是由表面特性和被困空气的相互作用所支配的.
- 这些材料显示出长期,局部治疗应用的巨大潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

